Abstract:Objective:To explore the effect of miR-3607-3p on the malignant phenotype of cervical cancer cells and related mechanisms.Methods:The OncoLnc bioinformatics website was used to analyze the relationship between the expression of miR-3607-3p and the prognosis of cervical cancer patients. Real time fluorescent quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-3607-3p in human normal cervical epithelial cells (H8) and cervical cancer cell lines (Hela, HCC94, SiHa, C33A). SiHa cells transfected with negative control nucleotide sequence in vitro were defined as negative control (NC) group, and SiHa cells transfected with miR-3607-3p mimicked sequence was defined as miR-3607-3p group. qRT-PCR was used to detect the expression changes of miR-3607-3p in SiHa cells. Cell counting kit-8 (CCK-8) method and scratch test were used to detect the malignant biological behavior changes of SiHa cells. qRT-PCR and Western blot were used to detect the expression changes of profilin 2 (PFN2) gene, and the dual luciferase reporter gene experiment was used to detect the targeting relationship between miR-3607-3p and PFN2. Results:The survival time of patients with high expression of miR-3607-3p was significantly higher than that of patients with low expression of miR-3607-3p ( P<0.01). Compared with H8 cells, the expression of miR-3607-3p was abnormally low in human cervical cancer cell lines ( P<0.05), and the expression of miR-3607-3p was the lowest in the SiHa cell line ( P<0.01). The expression of miR-3607-3p in the NC group and miR-3607-3p group was (1.04±0.31) and (9.28±1.76), respectively. The expression level of miR-3607-3p in SiHa cells transfected with miR-3607-3p mimic sequence was significantly higher than that in NC group, and the proliferation activity and scratch healing rate were significantly lower than that in NC group (all P<0.01). Dual-luciferase reporter gene assay confirmed that miR-3607-3p directly targeted and binded to PFN2 ( P<0.01). qRT-PCR and Western blot results showed that the expression of PFN2 mRNA and protein in miR-3607-3p group was lower than that in NC group; Western blot results showed the expression of proliferating proteins CDK3 and CDK2 in miR-3607-3p group was lower than that in NC group (all P<0.05), and the expression of epithelial phenotype related proteins Claudin-1 and ZO-1 in miR-3607-3p group was higher than that in NC group (all P<0.05). Conclusions:miR-3607-3p is positively correlated with the survival of cervical cancer patients. Up-regulating the expression of miR-3607-3p can inhibit the proliferation and migration of cervical cancer SiHa cells. The mechanism may be related to the targeted inhibition of PFN2.

MiR-499b-5p Inhibits Cervical Cancer Cell Proliferation and Induces Apoptosis by Targeting the Notch1 Signaling Pathway

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer

Microrna-499A Promotes the Progression and Chemoresistance of Cervical Cancer Cells by Targeting SOX6

Mir-141-5p Affects the Cell Proliferation and Apoptosis by Targeting BTG1 in Cervical Cancer

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

MiR-634 Decreases Cell Proliferation and Induces Apoptosis by Targeting Mtor Signaling Pathway in Cervical Cancer Cells

MiR-137 Inhibits Cervical Cancer Progression Via Down-Modulating Notch1 and Inhibiting the PI3K/AKT/mTOR Signaling Pathway

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway

MiR-875-5p Suppresses Cervical Cancer Cell Proliferation and Metastasis Via Negative Regulation of EGFR

miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway

MiR-495-3p and Mir-143-3p Co-Target CDK1 to Inhibit the Development of Cervical Cancer

MiR-34b Regulates Cervical Cancer Cell Proliferation and Apoptosis.

LncRNA MIR497HG inhibits cervical cancer by upregulating BCL6B to block PI3K/AKT signaling

MicroRNA-449a Is Downregulated in Cervical Cancer and Inhibits Proliferation, Migration, and Invasion.

Retracted: MicroRNA‐497 Accelerates Apoptosis While Inhibiting Proliferation, Migration, and Invasion Through Negative Regulation of the MAPK/ERK Signaling Pathway Via RAF‐1

miR-3607-3p inhibits the malignant biological behavior of cervical cancer cells by mediating the expression of profilin 2

MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2.

MiR-139-3p Induces Cell Apoptosis and Inhibits Metastasis of Cervical Cancer by Targeting NOB1.